Deal Watch: Allergan Buys Kythera Anticipating Kybella Will Bolster Its Aesthetic Portfolio

Johnson & Johnson Innovation announces a spate of 17 deals, bringing its two-year total to more than 200 agreements. Celgene pays $82.5 million up front to partner with Kythera on a ROR gamma T program for cancer immunotherapy.